Luteal phase support for assisted reproduction cycles

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 10, 2011, Pages

  van der Linden, Michelle ^a   Buckingham, Karen ^b   Farquhar, Cindy ^c   Kremer, Jan A M ^d   Metwally, Mostafa ^e  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; GONADORELIN; PROGESTERONE;

DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; LUTEAL PHASE; META ANALYSIS; PHYSIOLOGY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

CHORIONIC GONADOTROPIN; ESTROGENS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LIVE BIRTH; LUTEAL PHASE; PREGNANCY; PROGESTERONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 80355145116     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009154.pub2     Document Type: Review

References (214)

1. Abate A, Brigandi A, Abate FG, Manti F, Unfer V, Perino M. Luteal phase support with 17alpha-hydroxyprogesterone versus unsupported cycles in in vitro fertilization: a comparative randomized study. Gynaecologic and Obstetric Investigation 1999;48(2):78-80.
2. Abate A, Perino M, Abate FG, Brigandi A, Costabile L, Manti F. Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer. A comparative randomized study. Clinical and Experimental Obstetrics and Gynecology 1999;26:203-6.
3. Aboulghar MA, Amin YM, Al-Inany HG, Aboulghar MM, Mourad LM, Serour GI, et al.Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks. Human Reproduction 2008;23(4):857-62.
4. Albert J, Pfeifer S. Luteal phase hormone levels after in vitro fertilization and embryo transfer (IVF-ET): a prospective randomized trial of human chorionic gonadotropin (hCG) vs. intramuscular (im) progesterone (P) for luteal phase support following stimulation with gonadotropin-releasing hormone agonist (GnRH-a) and human menopausal gonadotropins (hMG) [abstract]. Fertility and Sterility. 1991:S18 (Abs # O-041).
5. Artini PG, Volpe A, Angioni S, Galassi MC, Battaglia C, Genazzani AR. A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program. Journal of Endocrinological Investigation 1995;18:51-6.
6. Ata B, Yakin K, Balaban B, Urman B. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study. Human Reproduction 2008;23(3):668-73.
7. Urman B. Single dose gonadotropin-releasing hormone (GnRH) agonist administration in the luteal phase of GnRH antagonist stimulated ICSI-ET cycles. Directly obtained from author, 17 March 2011. [: Clinicaltrials.gov: NCT01007851].
8. Beckers NGM, Laven JSE, Eijkemans MJC, Fauser BCJM. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. Human Reproduction 2000;15(1):43-9.
9. Belaisch-Allart J, Testart J, Fries N, Forman R G, Frydman R. The effect of dydrogesterone supplementation in an IVF programme. Human Reproduction 1987;2:183-5.
10. Belaisch-Allart J, Testart J, Fries N, Forman R, Hazout A, Declerc l, et al.The effect of dydrogesterone and hCG supplementation in an IVF program [abstract]. 5th World Congress on In Vitro Fertilization and Embryo Transfer Abstract Book. 1987:41 (Abs #PP-35).
11. Belaisch-Allart J, De Mouzon J, Lapousterle C, Mayer M. The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme. Human Reproduction 1990;5:163-6.
12. Caligara C, Carranza F, Ramos J, Rodriguez I, Gonzalez A, Fernandez-Sanchez M. Luteal phase support in IVF patients at low risk for OHSS: Progesterone vs. progesterone plus HCG. A prospective randomized study. Fertility and Sterility 2007;88:S163 (Abs#P-166).
13. Ceyhan ST, Basaran M, Kemal Duru N, Yilmaz A, Goktolga U, Baser I. Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study. Fertility and Sterility 2008;89(6):1827-30.
14. Chakravarty BN, Shirazee HH, Dam P, Chattopadhyay R, Ghosh S, Dam M, Goswami SK. A randomized prospective study comparing dydrogesterone and intravaginal micronised progesterone as luteal phase support in ART cycle [abstract]. Human Reproduction. 2004; Vol. 19:i126 (Abs #P-364).
15. Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: Results of a randomised study. Journal of Steroid Biochemistry and Molecular Biology 2005;97(5):416-20.
16. Colwell KA, Tummon IS. Elevation of serum progesterone with oral micronized progesterone after in vitro fertilization. Journal of Reproductive Medicine 1991;36:170-2.
17. Dal Prato L, Bianchi L, Cattoli M, Tarozzi N, Flamigni C, Borini A. Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial. Reproductive BioMedicine Online 2008;16(3):361-7.
18. Dal Prato L, Borini A, Bonu MA, Maccolini A, Cattoli M, Flamigni C. Luteal support in IVF: i.m. versus intravaginal progesterone. Human Reproduction. 2004 Suppl 1; Vol. 19:i69-70 (Abs #O-198).
19. Doody KJ, Schnell VL, Foulk RA, Miller CE, Kolb BA, Blake EJ, et al.Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation. Fertility and Sterility 2009;91(4):1012-7.
20. Drakakis P, Loutradis D, Vomvolaki E, Stefanidis K, Kiapekou E, Anagnostou E, et al.Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer. Gynecological Endocrinology 2007;23(11):645-52.
21. Dunstone T, Zosmer A, Hussain S, Tozer A, Paney N, Wilson C et a l. A comparison between Cyclogest pessaries and Crinone gel as luteal support in IVF-ET cycles [abstract]. British Fertility Society Annual Meeting Abstract Book. 1999:62 (Abs # FC21).
22. Elgindy EA, El-Haieg DO. Does luteal estradiol supplementation have a role in long agonist cycles? Does luteal estradiol supplementation have a role in long agonist cycles? [abstract]. Fertility and Sterility. 2010; Vol. 88, issue Suppl 1:164 (Abs #168).
23. Elgindy EA, El-Haieg DO, Mostafa MI, Shafiek M. Does luteal estradiol supplementation have a role in long agonist cycles?. Fertility and Sterility 2010;93(7):2182-8.
24. Engmann L, DiLuigi A, Schmidt D, Benadiva C, Maier D, Nulsen J. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertility and Sterility 2008;89(3):554-61.
25. Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, Donoso P, Papanikolaou E, et al.Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: A randomized controlled trial. Human Reproduction 2006;21(10):2628-32.
26. Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, van Steirteghem A, Devroey P. Progesterone Versus Progesterone Combined With Estradiol as Luteal Support in Cycles Stimulated With GnRH Antagonist/rec-FSH for IVF: A Randomized Clinical Trial [abstract]. Fertility and Sterility. 2005; Vol. 84, issue Suppl 1:s322 (Abs #P-475).
27. Friedler S, Raziel A, Schachter M, Cohen O, Yaron M, Tartakovsky L, et al.Characteristics of conceptional and non-conceptional cycles after IVF using micronized progesterone for luteal support: a comparative study of vaginal or oral administration [abstract]. Abstract Book 1. 1998; Vol. 13, issue Abstract Book 1:161 (Abs # P-063).
28. Friedler S, Raziel A, Schachter M, Strassburger D, Bukovsky I, Ron-El R. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration. Human Reproduction 1999;14(8):1944-8.
29. Fujimoto A, Osuga Y, Fujiwara T, Yano T, Tsutsumi O, Momoeda M et a l. Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles. Journal of Assisted Reproduction and Genetics 2002;19(12):550-4.
30. Fujimoto A, Osuga Y, Ooi N, Fujiwara T, Yano T, Taketani Y. Addition of hCG to progesterone as a luteal support improves pregnancy rates for patients with low mid-luteal oestradiol levels in IVF and ICSI [abstract]. Human Reproduction. 2001; Vol. 16, issue Suppl 1:143 (Abs #P-143).
31. Ganesh A, Chakravorty N, Mukherjee R, Goswami S, Chaudhury K, Chakravarty B. Comparison of oral dydrogesterone with progesterone gel and micronized progesterone for luteal support in 1, 373 women undergoing in vitro fertilization: a randomized clinical study. Fertility and Sterility 2011;95(6):1961-5. [DOI:].
32. Geber S, Maia L, Lauar I, Valle MP, Sampaio AC. Does recombinant LH combined to progesterone for luteal phase interfere in the outcome of assisted reproduction technique cycles? [abstract]. Fertility and Sterility 2007;88 Suppl 1:25 (Abs #66).
33. Geber S, Moreira ACF, De Paula SOC, Sampaio M. Comparison of two different vaginal progesterone for luteal phase support in cycles of assisted reproduction. Jornal Brasileiro de Reproducao Assistida 2006;10(1):17-21.
34. Geber S, Moreira ACF, de Paula SOC, Sampaio M. Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles. Reproductive BioMedicine Online 2007;14(2):155-8.
35. Geusa S, Causio F, Marinaccio M, Stanziano A, Sarcina E. Luteal phase support with progesterone in IVF/ET cycles: a prospective, randomized study comparing vaginal and intramuscular administration [abstract]. Human Reproduction 2001;16 Suppl 1:145 (Abs # P-111).
36. Golan A, Herman A, Soffer Y, Bukovsky I, Caspi E, Ron-El R. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles. Human Reproduction 1993;8:1372-5.
37. Gorkemli H, Ak D, Akyurek C, Aktan M, Duman S. Comparison of pregnancy outcomes of progesterone or progesterone plus estradiol for luteal phase support in ICSI-ET cycles. Gynecologic and Obstetric Investigation 2004;58(3):140-4.
38. Goudge CS, Nagel TC, Damario MA. Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: A randomized, controlled trial. Fertility and Sterility 2010;94(3):946-51.
39. Hurd W W, Randolph Jf J r, Christman G M, Ansbacher R, Menge A C, Gell J S. Luteal support with both estrogen and progesterone after clomiphene citrate stimulation for in vitro fertilization. Fertility and Sterility 1996;66:587-92.
40. Isik AZ, Caglar GS, Sozen E, Akarsu C, Tuncay G, Ozbicer T, et al.Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study. Reproductive BioMedicine Online 2009;19(4):472-7.
41. Isikoglu M, Ozgur K, Oehninger S. Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection. Journal of Reproductive Medicine 2007;52(7):639-44.
42. Iwase A, Ando H, Toda S, Ishimatsu S, Harata T, Kurotsuchi S, et al.Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: A prospective randomized study. Archives of Gynecology and Obstetrics 2008;277(4):319-24.
43. Kleinstein J. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction. Fertility and Sterility 2005;83(6):1641-9.
44. Kleinstein, J. Efficacy of Utrogest 200 and Crinone 8% for luteal phase support during ART: a comparative, multicenter study [Abstract]. Human Reproduction. 2004; Vol. 19:i123 (Abs #P-357).
45. Kohls G, Ruiz FJ, De La Fuente G, Toribio M, Martinez M, Pellicer A, et al.Early progesterone cessation after in vitro fertilization. Human Reproduction 2010;25 Suppl 1(6):i249 Abstract no. P-344.
46. Kupferminc MJ, Lessing JB, Amit A, Yovel I, David MP, Peyser MR. A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer. Human Reproduction 1990;5(3):271-3.
47. Lam PM, Cheung MC, Cheung LP, Lok HI, Haines CJ. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer. Gynecological Endocrinology 2008;24(12):674-80.
48. Lewin A, Benshushan A, Mezker E, Yanai N, Schenker JG, Goshen R. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support. Fertility and Sterility 1994;62:121-5.
49. Licciardi F, Kwiatkowski A, Noyes N, Berkeley AS, Krey LL, Grifo JA. Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertility and Sterility 1999;71:614-8.
50. Loh SKE, Leong NKY. Luteal phase support in IVF-cycles - is intramuscular progesterone the therapy of choice? [abstract]. Fertility Society of Australia XV Annual Meeting Abstract Book (Abs #O24). 1996.
51. Ludwig M, Finas A, Bals-Pratsch M, Felberbaum RE, Schopper B, Al-Hasani S, et al.Prospective, randomized study to evaluate the pregnancy rate using HCG, vaginal progesterone (Utrogest), or a combination of both for luteal-phase support: preliminary results [abstract]. Human Reproduction. 1999; Vol. 14 Suppl 1:2-3 (Abs # O-004).
52. Ludwig M, Finas A, Katalinic A, Strik D, Kowalcek I, Schwartz P et a l. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support. Acta Obstetricia et Gynecologica Scandinavica 2001;80:574-82.
53. Ludwig M, Schwartz P, Babahan B, Katalinic A, Bals-Pratsch M, Diedrich K. Progesterone gel (Crinone 8%) is more comfortable than progesterone suppositories (Utrogest) for luteal phase support and results in comparable pregnancy rates: results of a prospective, randomized study [abstract]. Fertility and Sterility. 2000; Vol. 74:S210 (Abs #P-S210).
54. Ludwig M, Schwartz P, Babahan B, Katalinic A, Weiss JM, Felberbaum R et a l. Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study. European Journal of Obstetrics and Gynaecology 2002;103:48-52.
55. Schwartz P, Ludwig M, Babahan B, Katalinic A, Bals-Pratsch M, Felberbaum R, et al.Luteal phase support using either progesterone gel (Crinone 8%) or progesterone suppositories (Utrogest): results of a prospective, randomized study [abstract]. Human Reproduction 2000;15(Abstract Book 1):43-4 (Abs #O-111).
56. Macrolin G, Buvat J, Guittard C, Herbaut JC, Louvet AL, Dehaene JL. [Fécondation in vitro après agoniste de la LHRH: comparison randomisée de soutiens lutéaux par progestérone vaginale seule ou associee a la gonadotrophine chorionique]. Contraception Fertilité Sexualité 1993;21(5):434.
57. Martinez F, Coroleu B, Parera N, Alvarez M, Traver JM, Boada M et a l. Human chorionic gonadotropin and intravaginal natural progesterone are equally effective for luteal phase support in IVF. Gynaecological Endocrinology 2000;14:316-20.
58. Miller CE, Doody KJ, Zbella E, Webster B, Bush M, Scobey J. Efficacy of vaginal progesterone inserts (Endometrin) compared to intramuscular progesterone in oil for luteal support in IVF patients. Fertility and Sterility 2010;94 Suppl 1(4):20-1 Abstract no. O-68.
59. Ng EHY, Miao B, Cheung W, Ho PC. A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles. European Journal of Obstetrics Gynecology and Reproductive Biology 2003;111:50-4.
60. Ng EHY, Chan CCW, Tang OS, Ho PC. A randomized comparison of side effects and patient convenience between Cyclogest suppositories and Endometrin tablets used for luteal phase support in IVF treatment. European Journal of Obstetrics Gynecology and Reproductive Biology 2007;131(2):182-8.
61. Patki A, Pawar VC. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone. Gynecological Endocrinology 2007;23 Suppl 1:68-72.
62. Perino M, Brigandi A, Abate FG, Costabile L, Balzano E, Abate A. Intramuscular versus vaginal progesterone in assisted reproduction: a comparative study. Clinical and Experimental Obstetrics and Gynecology 1997;24:228-31.
63. Pirard C, Donnez J, Loumaye E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: Results of a pilot study. Human Reproduction 2006;21(7):1894-900.
64. Porcu E. Intramuscular versus vaginal progesterone in assisted reproduction [abstract]. Fertility and Sterility. 2003; Vol. 80:S131 (Abs # P-32).
65. Pouly JL, Bassil S, Frydman R, Hedon B, Nicollet B, Prada Y et a l. Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone. Human Reproduction 1996;11:2085-9.
66. Pouly JL, Bassil S, Frydman R, Hedon B, Nicollet B, Prada Y, et al.Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone. Contraception, Fertilité, Sexualité 1997;25:596-601.
67. Propst AM, Hill JA, Ginsburg ES, Hurwitz S, Politch J, Yanushpolsky EH. A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertility and Sterility 2001;76:1144-9.
68. Propst AM, Hill JA, Politch J, Yanushpolsky EH. A prospective, randomized study comparing Crinone and intramuscular progesterone supplementation in IVF/ET cycles [abstract]. Fertility and Sterility. 2000; Vol. 74:s30-1 (Abs #O-084).
69. Qublan H, Amarin Z, Al-Quda M, Diab F, Nawasreh M, Malkawi S, et al.Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of [less-than or equal to]7 mm on day of egg retrieval. Human Fertility 2008;11(1):43-7.
70. Rodriguez-Pezino J, Saucedo-de la Llata E, Batiza-Resendiz V, Galache-Vega P, Santos-Haliscak R, Hernandez-Ayup S, et al.Vaginal progesterone in assisted reproduction. Human Reproduction. Berlin, Germany, 2004; Vol. 19 Suppl 1:i51.
71. Saucedo-de la Llata E, Galache VP, Hernandez AS, Santos HR, Arenas ML, Patrizio P. Randomized trial of three different forms of progesterone supplementation in ART: preliminary results [abstract]. Fertility and Sterility 2000;74 Suppl 1:S150 (Abs # P-175).
72. Saucedo-de la Llata E, Batiza V, Arenas L, Santos R, Galache P, Hernandez-Ayup S, et al.Progesterone for luteal support: randomized, prospective trial comparing vaginal and i.m. administration [abstract]. Fertility and Sterility 2003;18 Suppl 1:130 (Abs # P-382).
73. Serna J, Cholquevilque JL, Cela V, Martinez-Salazar J, Requena A, Garcia-Velasco JA. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. Fertility and Sterility 2008;90(6):2190-5.
74. Stadtmauer LA, Reape KZ, Shu H. Luteal supplementation with a weekly progesterone vaginal ring in infertile women undergoing in vitro fertilization (IVF). Fertility and Sterility. Denver, CO United States, 2010; Vol. 94 Suppl 1:244.
75. Strehler E, Abt M, El-Danasouri I, Sterzik K. Transvaginal administration of micronized progesterone does not differ to progesterone gel application in the efficacy of luteal phase support in IVF cycles [abstract]. 11th World Congress of In Vitro Fertilization and Human Reproductive Genetics Abstract Book. 1999:287 (Abs # P-243).
76. Sumita S, Sofat S Sr. Intra muscular versus intra vaginal progesterone as luteal phase and early pregnancy support in patients undergoing IVF-ET [abstract]. Fertility and Sterility 2003;80 Suppl 3:134-5 (Abs # P-44).
77. Tay PYS, Lenton EA. The impact of luteal supplement on pregnancy outcome following stimulated IVF cycles. Medical Journal of Malaysia 2005;60(2):151-7.
78. Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Human Reproduction 2006;21(10):2572-9.
79. Torode HW, Porter RN, Vaughan JI, Saunders DM. Luteal phase support after in vitro fertilisation: a trial and rationale for selective use. Clinical Reproduction and Fertility 1987;5:255-61.
80. Ugur M, Yenicesu O, Ozcan S, Keles G, Gokmen O. A prospective randomized study comparing hCG, vaginal micronized progesterone and a combination regimen for luteal phase support in an in-vitro fertilization programme [abstract]. Fertility and Sterility 2001;76 Suppl 1:118 (Abs # P-19).
81. Vimpeli T, Tinkanen H, Huhtala H, Ronnberg L, Kujansuu E. Salivary and serum progesterone concentrations during two luteal support regimens used in in vitro fertilization treatment. Fertility and Sterility 2001;76:847-8.
82. Wong YF, Loong EPL, Mao KR, Tam PPL, Panesar NS, Neale E, et al.Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens. Reproduction Fertility and Development 1990;2:351-8.
83. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M. Compared to Crinone, intramuscular progesterone (IMP) delays menstrual bleeding but does not improve pregnancy rates or outcomes in IVF/ET cycles. Fertility and Sterility. 2009; Vol. 92 Suppl 1:243.
84. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M. Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: A prospective randomized study. Fertility and Sterility 2010;94(7):2596-9.
85. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M. Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone - Impact of luteal estrogen: Prospective, randomized study and post hoc analysis. Fertility and Sterility 2011;95(2):617-20.
86. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein MD. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. Fertility and Sterility 2008;89(2):485-7.
87. Zegers-Hochschild F, Balmaceda J P, Fabres C, Alam V, Mackenna A, Fernández E et a l. Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation. Human Reproduction 2000;15(10):2093-7.
88. Zegers-Hochschild F, Balmaceda JP, Fabres C, Alam V, Mackenna A, Fernandez E, et al.Efficacy and acceptability of a vaginal ring releasing progesterone for in-vitro fertilization and oocyte donation [abstract]. 1998; Vol. 13, issue Abstract Book 1:118-9 (Abs #O-231).
89. Abu-Musa A, Usta I, Nassar A, Hajami F, Hannoun A. Effect of 17alpha-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial. Fertility and Sterility 2008;89(5):1098-102.
90. Abu-Musa A, Usta I, Nassar A, Hajami F, Hannoun A. Effect of 17alpha-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial. Fertility and Sterility 2008;89(5):1098-102.
91. Allahbadia GN, Kaur K, Kadam K, Virk S, Gandhi G, Gosrani S. The comparison of pregnancy outcomes of intramuscular progesterone versus oral dydrogesterone for luteal phase support in donor egg IVF recipient cycles. Fertility and Sterility 2004;82 Suppl 2:194.
92. Allen C, Harrison RF. Luteal support progesterone vaginal gel v pessary: clinical/endocrine outcome. Human Reproduction 2004;19 Suppl:i125-6.
93. Alsanie A, Kadoch I, Phillips S, Lapensee L, Hemmings R, Bissonnette F. Adding estrogen to progesterone in luteal phase support in vitro fertilization-embryo transfer (IVF-ET) cycles produces pregnancies with higher quantitative beta human chorionic gonadotropins (beta hCG). Fertility and Sterility 2005;84 Suppl:155.
94. Anserini P, Costa M, Remorgida V, Sarli R, Guglielminetti E, Ragni N. Luteal phase support in assisted repoductive cycles using either vaginal (Crinone 8) or systemic (Prontogest) progesterone: results of a prospective randomized study. Minerva Ginecologica 2001;53:297-301.
95. Anthony F W, Smith E M, Gadd S C, Masson G M, Chard T, Perry L. Placental protein 14 secretion during in vitro fertilization cycles with and without human chorionic gonadotropin for luteal support. Fertility and Sterility 1993;59:187-91.
96. Araujo E Jr, Bernardini L, Frederick JL, Asch RH, Balmaceda JP. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. Journal of Assisted Reproduction and Genetics 1994;11(2):74-8.
97. de Araujo Filho E, Asch RH, de Araujo E, Luz OA, Balmaceda JP. Prospective and randomized trial comparing human chorionic gonadotropin and intramuscular progesterone for luteal phase support in assisted fertilization [Estudo prospectivo e randomizado comparando gonadotrofina coriônica humana e progesterona intramuscular para suporte da fase lútea em reproduçao assistida]. Revista Brasileira de Ginecologia e Obstetrica 1996;18(2):131-7.
98. Baber R J, Kuan R, Porter R N, Saunders D M. Early pregnancy support in an in vitro fertilization program: does human chorionic gonadotropin reduce the miscarriage rate?. Asia-Oceania Journal of Obstetrics and Gynaecology 1988;14:453-5.
99. Beckers NGM, Platteau P, Eijkemans MJ, Macklon NS, de Jong FH, Devroey P, et al.The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. European Journal of Endocrinology 2006;155(2):355-63.
100. Belaisch-Allart J, de Mouzon J. Effect of luteal phase supplementation in an IVF programme after ovarian stimulation by LH-RH analogs. Multicentric analysis [Effet de la supplementation de la phase luteale dans un programme de fecondation in vitro apres stimulation de l'ovulation par les agonistes du LHRH. Etude multicentrique]. Contraception, Fertilite, Sexualite 1988;16(7):654-6.
101. Ben-Nun I, Ghetler Y, Jaffe R, Siegal A, Kaneti H, Fejgin M. Effect of preovulatory progesterone administration on the endometrial maturation and implantation rate after in vitro fertilization and embryo transfer. Fertility and Sterility 1990;53:276-81.
102. Berjis K, Sarem A, Moaya M, Mohamad Alayha N. The comparative assessment of intramuscular progesterone and intravaginal progesterone to support luteal phase in IVF cycle [Farsi]. Medical Sciences Journal of the Islamic Azad University of Tehran Medical Unit 2008;18(1):9.
103. Blake EJ, Norris PM, Dorfman SF, Longstreth J, Yankov VI. Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects. Fertility and Sterility 2010;94(4):1296-301.
104. Buvat J, Marcolin G, Herbaut J C, Dehaene J L, Verbecq P, Fourlinnie J C. A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer. Fertility and Sterility 1988;49:458-61.
105. Macrolin G, Buvat J, Herbaut JC, Louvet AL, Dehaene JL, Renouard O. Luteal phase support with HCG - can it be of any benefit following in vitro fecundation (IVF)? A controlled randomized study covering 116 cycles [Le soutien de la phase lutéale par HCG a-t-il de l'intérêt après fécondation in vitro?]. Gynecologie 1988;39:163-6.
106. Buvat J, Marcolin G, Guittard C, Dehaene JL, Herbaut JC, Louvet AL. Luteal support after administration of an LHRH analog for in vitro fertilization. Superiority of vaginal progesterone in comparison with oral progesterone [Soutien lutéal après analogue de la gonadoréline pour fécondation in vitro. Supériorité de la progestérone vaginale sur la progestérone orale]. La Presse Médicale 1990;19:527.
107. Buvat J, Marcolin G, Guittard C, Herbaut JC, Louvet AL, Dehaene JL. Luteal phase support after LHRH-agonist for in vitro fertilization (IVF): vaginal progesterone is superior to oral progesterone and as much effective as human chorionic gonadotropin (hCG) [Soutien lutéal après LHRH-agonistes pour fécondation in vitro: la progestérone vaginale est supérieure à la progestérone orale, et aussi efficace que la gonadotrophine chorionique (hCG)]. Contraception Fertilite Sexualite 1990;18:616-7.
108. Buvat J, Marcolin G, Guittard C, Herbaut JC, Louvet AL, Dehaene JL. Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone. Fertility and Sterility 1990;53:490-4.
109. Buvat J, Mercolin G, Guittard C, Dehaene JL, Verbecq P, Renouard O, et al.Chorionic gonadotropin support of the luteal phase following in vitro fertilization and embryo transfer. Randomized comparison wih oral progesteronein protocols using triptoreline [Soutien de la phase lutéal par la gonadotrophine chorionique après fécondation in vitro et transfert d'embryon. Comparaison randomisée à la progestérone per os dans les protocoles utilitsant la triptoréline]. La Presse Médicinale 1989;18:539.
110. Casini ML, Unfer V, Costabile L, Gerli S, Agostini R, Di Renzo GC. Oral versus i.m. progesterone supplementation in IVF-embryo transfer cycles: a randomized study [abstract]. Human Reproduction 2003;18 Suppl 1:106 (Abs # P-307).
111. Chang Sheng-Ping. Comparison of Crinone 8% Intravaginal Gel and Intramuscular Progesterone for Luteal Support in In Vitro Fertilization. Journal of the Chinese Medical Association 2008;71(8):381-5.
112. Chang HJ, Lee JR, Jee BC, Suh CS, Kim SH. Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocol. Journal of Korean Medical Science 2009;24(2):262-8.
113. Chantilis S J, Zeitoun K M, Patel S I, Johns D A, Madziar V A, McIntire D D. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertility and Sterility 1999;72:823-9.
114. Check J H, Dietterich C, Cohen R, Choe J K, Amui J, Brasile D. Increasing the dosage of progesterone (P) supplemention from the mid-luteal phase in women not attaining a mid-luteal homogeneous hyperechogenic (HH) pattern with sonography improves pregnancy rates (PRS) following frozen embryo transfer (ET). Clinical and Experimental Obstetrics and Gynecology 2010;37(1):13-4.
115. Claman P, Domingo M, Leader A. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone. Human Reproduction 1992;7(4):487-9.
116. Daya S. Luteal support: progestogens for pregnancy protection. Maturitas 2009;65 Suppl 1:29-34.
117. Ding J, Rana N, Dmowski W. Comparative Effectiveness of two Luteal Phase Support Protocols for IVF. Fertility and Sterility 2005;84 Suppl 1:349.
118. Erman Akar M, Kursun S, Taskin O, Simsek M, Kaba M, Uner M. Intravaginal progesterone gel vs 17oe hydroxyprogesterone caproate in ICSI embryo transfer cycles: A prospective randomized study. Fertility and Sterility 2005;84 Suppl 1:320.
119. Escriba MJ, Bellver J, Bosch E, Sanchez M, Pellicer A, Remohi J. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. Fertility and Sterility 2006;86(1):92-7.
120. Farhi J, Weissman A, Steinfeld Z, Shorer M, Nahum H, Levran D. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertility and Sterility 2000;73:761-6.
121. Farrag A, Costantini A, Manna C, Grimaldi G. Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI. Journal of Assisted Reproduction and Genetics 2008;25(9-10):461-6.
122. Feliciani E, Ferraretti AP, Balicchia B, Grieco N, Magli MC, Gianaroli. A prospective randomised study comparing the effect of intravaginal progesterone and intramuscular progesterone in frozen/thawed embryo transfer (FET) cycles. Human Reproduction 2004;82:i51.
123. Garcia-Velasco J, Motta L, Lopez A, Mayoral M, Cerrillo M, Pellicer A, Pacheco A. Estradiol/progesterone vs low dose hCG luteal phase support in GnRH agonist triggered ART cycles: A pilot study. Human Reproduction 2010;25 Suppl 1:i86 (Abs #O-224).
124. Garcia-Velasco JA, Quea G, Piro M, Mayoral M, Ruiz M, Toribio M, et al.Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial. Fertility and Sterility 2009;92(1):222-5.
125. Ghanem M, Sadek E, Helal A, Gamal A, Eldiasty E, Bakre NI, Houssen M. The effect of luteal phase support protocol on luteal phase serum estradiol and progesterone and cycle outcome in ICSI cycles: a randomized trial [Abstract]. Human Reproduction. 2008; Vol. 23, issue Suppl 1:i124 (Abs #P-307).
126. Ghanem ME, Sadek EE, Elboghdady LA, Helal AS, Gamal A, Eldiasty A, et al.The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial. Fertility and Sterility 2009;92(2):486-93.
127. Gibbons W E, Toner J P, Hamacher P, Kolm P. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertility and Sterility 1998;69:96-101.
128. Griesinger G, Diedrich K. Vaginal progesterone for luteal phase support in assisted reproduction [Die vaginale Anwendung von natürlichem Progesteron als Lutealphasenunterstützung nach IVF und Embryotransfer]. Geburtsh Frauenheilk 2006;66:655-64.
129. Herman A, Ron-El R, Golan A, Raziel A, Soffer Y, Caspi E. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins. Fertility and Sterility 1990;53:92-6.
130. Herman A, Raziel A, Nachum H, Strassburger D, Soffer Y, Bukovsky Y, et al.The benefits of midluteal addition of human chorionic gonadotrophin in IVF using a down-regulation protocol and luteal support with progesterone [abstract]. Human Reproduction 1995;10(Abstract Book 2):63 (Abs #127).
131. Herman A, Raziel A, Strassburger D, Soffer Y, Bukovsky I, Ron-El R. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone. Human Reproduction 1996;11:1552-7.
132. Ho CH, Chen SU, Peng FS, Chang CY, Yang YS. Luteal support for IVF/ICSI cycles with Crinone 8% (90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone. Journal of the Chinese Medical Association 2008;71(8):386-91.
133. Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C. 1, 500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertility and Sterility 2010;93(3):847-54.
134. Hutchinson-Williams KA, DeCherney AH, Lavy G, Diamond MP, Naftolin F, Lunenfeld B. Luteal rescue in in vitro fertilization-embryo transfer. Fertility and Sterility 1990;53:495-9.
135. Jee BC, Suh CS, Kim SK, Kim YB, Moon SY. Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis. Fertility and Sterility 2010;93(2):428-36.
136. Johnson M R, Okokon E, Collins W P, Sharma V, Lightman S L. The effect of human chorionic gonadotropin and pregnancy on the circulating level of relaxin. Journal of Clinical Endocrinology and Metabolism 1999;72:1042-7.
137. Kahraman S, Karagozoglu SH, Karlikaya G. The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial. Fertility and Sterility 2010;94(2):761-3.
138. Karagozoglu H, Kahraman S, Karlikaya G, Kavrut M, Ersahin A. The efficiency of vaginal gel vs intramuscular progesterone for luteal phase support in GnRH antagonist cycles: A prospective, randomized trial. Human Reproduction. 2009; Vol. 24 Suppl 1:i109-10 (Abs #O-273).
139. The Corifollitropin Alfa Dose-finding Study Group. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Human Reproduction 2008;23(11):2484-92.
140. Krause BT, Ohlinger R. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development. European Journal of Obstetrics Gynecology and Reproductive Biology 2006;126(1):87-92.
141. Krischker U, Poehl M, Bichler K, Feichtinger W. Different methods of luteal phase support in an in vitro fertilization (IVF) program [abstract]. Fertility and Sterility 1998;70 Suppl 1:327 (Abs # P-639).
142. Lam PM, Cheung LP, Haines CJ. Early luteal phase progesterone supplementation and IVF-ET outcome [abstract]. Reproduction 2003;Abstract Series #30:51 (Abs # P2).
143. Lan VTN, Tuan P, Canh L, Tuong H, Howles CM. Comparison of the efficacy and tolerability of two formulations of vaginal progesterone for luteal phase support in frozen embryo transfer cycles. Fertility and Sterility 2007;88 Suppl 1:164 (Abs #169).
144. Leeton J, Trounson A, Jessup D. Support of the luteal phase in in vitro fertilization programs: results of a controlled trial with intramuscular proluton. Journal of In Vitro Fertilization and Embryo Transfer 1985;2:166-9.
145. Lightman A, Kol S, Itskovitz-Eldor J. A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles. Human Reproduction 1999;14:2596-9.
146. Lukaszuk K, Liss J, Lukaszuk M, Maj B. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertility and Sterility 2005;83(5):1372-6.
147. Mahadevan M M, Leader A, Taylor P J. Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer. Journal of In Vitro Fertilization and Embryo Transfer 1985;2:190-4.
148. Marianowski P, Radwanska E. Intramuscular vs vaginal progesterone for luteal support in cycles of in vitro fertilization. Ginekologia Polska 2000;71:1064-70.
149. Martins WdP. Suporte da fase lutea. Femina 2010;38(5):271.
150. McBain J C, Clarke G A, Molloy D, Yeates J, Johnston W I H, McKenna M. A randomized trial of progesterone support following ovarian stimulation with clomiphene hMG for IVF and GIFT [abstract]. 5th World Congress on In Vitro Fertilization and Embryo Transfer Abstract Book. 1987:75 (Abs # PP-126).
151. Mochtar M H, Hogerzeil H V, Mol B W J. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial. Human Reproduction 1996;11:1602-5.
152. Moraloglu O, Kilic S, Karayalcin R, Yuksel B, Tasdemir N, Isik A, et al.Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients. Advances in Therapy 2008;25(3):266-73.
153. Nader S, Berkowitz A S, Ochs D, Held B, Winkel C A. Luteal-phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: progesterone versus human chorionic gonadotropin. Journal of In Vitro Fertilization and Embryo Transfer 1988;5:81-4.
154. Nikkanen V, Kresanov I, Makinen J, Vuorento T. The effect of luteal support with human chorionic gonadotrophin or progesterone on the daily progesterone profile after different types of ovarian stimulation. Human Reproduction 1992;7:333-6.
155. Ozcimen EE, Ugur M, Ozcimen N, Yilmaz Z. Is luteal phase support with hCG or vaginal micronised progesterone beneficial in non-IVF gonadotropin induction of ovulation?. Fertility and Sterility 2004;82 Suppl 2:142.
156. Papanikolaou E, Werpoest W, Fatemi H, Polyzos N, Humaidan P, Tarlatzis B, et al.Recombinant LH as luteal supplementation method after agonist triggering in IVF. A proof of concept study [abstract]. Human Reproduction. 2010; Vol. 25:i167-8 (Abs #P-134).
157. Papanikolaou EG, Fatemi H, Kyrou D, Polyzos NP, Humaidan P, Tarlatzis B, Devroey P, Tournaye H. Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial. Fertility and Sterility 2010;94(7):2902-4.
158. Pirard C, Donnez J, Loumaye E. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin. Human Reproduction 2005;20(7):1798-804.
159. Polson DW, Rogers PAW, Krapez JA, Leeton JF. Vaginal progesterone as luteal phase support in an IVF/GIFT programme. European Journal of Obstetrics Gynecology and Reproductive Biology 1992;46(1):35-8.
160. Schwarzler P, Abendstein BJ, Klingler A, Kreuzer E, Rjosk HK. Prevention of severe ovarian hyperstimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression - A prospective randomized study. Human Fertility 2003;6(3):125-9.
161. Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertility and Sterility 2007;87(1):83-7.
162. Singh T, Majumdar A. Supplementation of gonadotrophin releasing hormone (GnRH) agonist during the luteal phase improves the pregnancy outcome in intrauterine insemination (IUI) cycles, when compared with human chorionic gonadotrophin (hCG). Journal fur Reproduktionsmedizin und Endokrinologie. Munich, Germany, 2010:277 (Abs 15-7).
163. Smith E M, Anthony F W, Gadd S C, Masson G M. Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme. BMJ 1989;298:1483-6.
164. Smitz J, Devroey P, Camus M, Deschacht J, Khan I, Staessen C, et al.The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Human Reproduction 1988;3(5):585-90.
165. Smitz J, Devroey P, Faguer B, Bourgain C, Camus M, van Steirteghem A. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Human Reproduction 1992;7:168-75.
166. Smitz J, Devroey P, Faguer B, Bourgain C, Camus M, van Steirteghem AC. A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route [Etude prospective randomisee comparant la supplementation de la phase luteale et de la grossesse debutante par la progesterone naturelle administree par voie intra-musculaire ou vaginale]. Revue Francaise de Gynecologie et d Obstetrique 1992;87(10):507-516.
167. Smitz J, Bourgain C, Van Waesgerghe L, Camus M, Devroey P, Van Steirteghem AC. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Human Reproduction 1993;8:40-5.
168. Sordal T, Kahn J A, Sunde A, von Düring V, Molne K. A prospective randomized study comparing natural progesterone administered intramuscularly and vaginal micronized progesterone for luteal support [abstract]. Human Reproduction 1993;8 Suppl 1:39 (Abs # 99).
169. Stadtmauer L, Harrison DD, Boyd J, Bocca S, Oehninger S. Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients. Fertility and Sterility 2009;92(5):1600-5.
170. Tay PY, Lenton EA. Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles. Medical Journal of Malaysia 2003;58(2):187-95.
171. Trounson A, Howlett D, Rogers P, Hoppen H O. The effect of progesterone supplementation around the time of oocyte recovery in patients superovulated for in vitro fertilization. Fertility and Sterility 1986;45:532-5.
172. Unfer V, Casini M, Costabile L, Gerli S, Baldini D, Di Renzo GC. 17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study. Reproductive BioMedicine Online 2004;9(1):17-21.
173. Unfer V, Casini ML, Gerli S, Costabile L, Mignosa M, Di Renzo GC. Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial. Fertility and Sterility 2004;82(6):1509-13.
174. Valentino V, Artini P G, Ruggiero M, Parisen Toldin M R, Cristello F, et al.A randomised comparison of effects and patient inconvenience of two progesterone supplementation used in in vitro fertilisation cycles. Gynaecological Endocrinology 2004;18 Suppl 1:358 (Abs # P-170).
175. van Steirteghem AC, Smitz J, Camus M, Van Waesberghe L, Deschacht J, Khan I, et al.The luteal phase after in-vitro fertilization and related procedures. Human Reproduction 1988;3:161-4.
176. Var T, Aysin Tonguc E, Doganay M, Gulerman C, Gungor T, Mollamahmutoglu L. A comparison of the effects of three different luteal phase support protocols on in vitro fertilization outcomes: a randomized clinical trial. Fertility and Sterility 2011;95:985-9.
177. Wang LJ, Huang FJ, Kung FT, Lin PY, Chang SY, Lan KC. Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers. Taiwanese Journal of Obstetrics & Gynecology 2009;48(4):375-9.
178. Wilcox J, Nelson JR, Potter D, Frederick J, Feinman M, Batzofin J. Comparison of different luteal phase support protocols for frozen embryo transfer (FET) [abstract]. Fertility and Sterility 2001;76 Suppl 1:124 (Abs # P-37).
179. Ye H, Huang GN, Zeng PH, Pei L. IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: A prospective and randomized study. Journal of Assisted Reproduction and Genetics 2009;26(2-3):105-11.
180. Yigit N, Halicigil C, Basaran M, Aksu T, Yarali H. Crinone and i.m. progesterone yield comparable pregnancy rates following ICSI and embryo transfer [title only]. Human Reproduction 2002;17(Abstract Book 1):201 (Abs # R-624).
181. Yovich JL, Stanger JD, Yovich JM, Tuvik AI. Assessment and hormonal treatment of the luteal phase of in vitro fertilization cycles. Australian & New Zealand Journal of Obstetrics & Gynaecology 1984;24:125-30.
182. Yovich J L, McColm S C, Yovich J M, Matson P L. Early luteal serum progesterone concentrations are higher in pregnancy cycles. Fertility and Sterility 1985;44:185-9.
183. Yovich JL, Rohini Edirisinghe W, Cummins JM. Evaluation of luteal support therapy in a randomized controlled study within a gamete intrafallopian transfer program. Fertility and Sterility 1991;55:131-9.
184. Esra T, Var T, Citil A, Dogan M, Cicek N. Estradiol supplementation in luteal phase: How much matter?. Human Reproduction. Rome, Italy, 2010; Vol. 25 Suppl 1:i307-8.
185. Gallardo LE, Ayón P, Neuspiller F. [Estudio de dos vías diferentes de administración de progesterona micronizada en reproducción asistida]. Ginecología y Obstetricia de México 2004;72(8):407-10.
186. Humaidan P, Bungum L, Bungum M, Andersen CY. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reproductive BioMedicine Online 2006;13(2):173-8.
187. Jung YH, Kim YY, Kim MH, Cho JD. The best luteal phase support protocol for patients who had E2 levels <1500 pg/ml on the hCG day in a long GnRH agonist cycles. Fertility and Sterility 2010;94 Suppl 1(4):177.
188. Mochtar MH, Van Wely M, Van der Veen F. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles. Human Reproduction 2006;21(4):905-8.
189. Paredes Chavez FC, Barros Delgadillo JC, Ochoa Rueda SS, Barroso Villa G, et al.[Papel de los estrógenos en el soporte de la fase lútea en ciclos de fertilización in vitro con transferencia de embriones]. Ginecología y Obstetricia de México 2004;72(12):645-55.
190. Shamma F, Haj-Hassan L, Penzias A, Gutmann J, Leykin L, Jones E. Luteal phase support in in vitro fertilization embryo transfer (IVF-ET) - a prospective randomized trial [abstract]. American Fertility Society 48th Annual Meeting Abstract Book. 1992:S140-1 (Abs # P-074).
191. Silverberg K, Vaughn TC, Hansard L, Burger N, Minter T. Progesterone vaginal gel vs. intramuscular progesterone in oil for luteal support in IVF: a large, prospective trial [abstract]. Fertility and Sterility. 2010; Vol. Suppl 1:21 (Abs # O-69).
192. Balasch J. The role of FSH and LH in ovulation induction: current concepts and the contribution of recombinant gonadotropins. In: Gardner DK, Weissman A, Howles and Shoham V editor(s). Textbook of Assisted Reproductive Techniques. Laboratory and Clinical Perspectives. 2nd Edition. London and New York: Taylor & Francis, 2004:541-565.
193. Centers for Disease Control and Prevention ASfRM, Society for Assisted Reproductive Technology 2007. Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports, Atlanta. US Department of Health and Human Services, Centres for Disease Control and Prevention 2009.
194. Chan CC, Ng EH, Chan MM, Tang OS, Lau EY, Yeung WS, et al.Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women. Human Reproduction 2003;18(11):2294-7.
195. Choavaratana R, Manoch D. Efficacy of oral micronized progesterone when applied via vaginal route. Journal of the Medical Association of Thailand 2004;87(5):455-8.
196. de Mouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V, et al.Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Human Reproduction 2010;25(8):1851-62.
197. Edwards RG, Steptoe PC, Purdy JM. Establishing full-term human pregnancies using cleaving embryos grown in vitro. British Journal of Obstetrics and Gynaecology 1980;87(9):737-56.
198. Farquhar C, Roberts H. Introduction to Obstetrics and Gynaecology. Third Edition. Auckland: Department of Obstetrics & Gynaecology, The University of Auckland, 2010.
199. Fatemi HM. The luteal phase after 3 decades of IVF: what do we know?. Reproductive Biomedicine Online 2009;19(4):4331.
200. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
201. Kerin JF, Broom TJ, Ralph MM, Edmonds DK, Warnes GM, Jeffrey R, et al.Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles. British Journal of Obstetrics and Gynaecology 1981;88(10):1021-8.
202. Mannaerts BM, Geurts TB, Odink J. A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration. Human Reproduction 1998;13(6):1461-4.
203. Messinis IE, Messini CI, Dafopoulos K. Luteal-phase endocrinology. Reproductive Biomedicine Online 2009;19(4):4314.
204. Miyake A, Aono T, Kinugasa T, Tanizawa O, Kurachi K. Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women. Journal of Endocrinology 1979;80(3):353-6.
205. Mochtar MH, Van der Veen F, Ziech M, van Wely M, Musters A. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI:].
206. Pabuccu R, Akar ME. Luteal phase support in assisted reproductive technology. Current Opinion in Obstetrics and Gynecology 2005;17(3):277-81.
207. Saal W, Glowania HJ, Hengst W, Happ J. Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin. Fertility and Sterility 1991;56(2):225-9.
208. Schindler AE. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. Maturitas 2009;65(1):S3-11.
209. Smitz J, Erard P, Camus M, Devroey P, Tournaye H, Wisanto A, et al.Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Human Reproduction 1992;7(9):1225-9.
210. Tavaniotou A, Devroey P. Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles. Fertility and Sterility 2003;80(3):654-5.
211. Tesarik J, Hazout A, Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Human Reproduction 2004;19(5):1176-80.
212. Wang YA, Chambers GM, et al.Assisted reproductive technology in Australia and New Zealand 2007. Assisted reproductive technology series no 13 Cat no PER 47 Canberra: AIHW 2009.
213. Wikland M, Borg J, Forsberg AS, Jakobsson AH, Svalander P, Waldenstrom U. Human Chorionic-Gonadotropin Self-Administered by the Subcutaneous Route to Induce Oocyte Maturation in an in-Vitro Fertilization and Embryo-Transfer Program. Human Reproduction 1995;10(7):1667-70.
214. Daya S, Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI:].